NY Times

FEBRUARY 18, 2022

Pero eso no es cierto para una buena parte del mundo. Todos queremos volver a la normalidad y declarar el fin del peligro de la COVID-19.

Vaccination 53

Vaccination Vaccine Drugs 53

NY Times

OCTOBER 15, 2020

Los expertos señalaron que las pausas en los ensayos de vacunas son comunes, aunque detener ensayos de medicamentos, como el de Eli Lilly, es poco frecuente. En ambos casos, dijeron, reconforta la cautela de las compañías.

55

55

BioTech 365

AUGUST 16, 2020

Invitrogen Powerease 500 Electroforesis Potencia Supply – Se Vende Es BioMarketplace You want to propose your … Continue reading → 143,90 EURFecha de finalización: miércoles sep-16-2020 1:33:08 CESTCómpralo ya por sólo: 143,90 EUR¡Cómpralo ya! |

40

40

pharmaphorum

DECEMBER 8, 2021

China’s Shanghai Henlius Biotech says its experimental PD-1 inhibitor serplulimab has extended survival when added to chemotherapy in a phase 3 trial as first-line therapy for extensive stage small cell lung cancer (ES-SCLC), setting up regulatory filings.

Drugs 98

Drugs Trials Clinical Trials Clinical Trials 98

Drug Discovery World

MARCH 1, 2024

This transaction brings a promising pipeline of RPTs to Bristol Myers Squibb, including RayzeBio’s lead programme RYZ101, which targets somatostatin receptor 2 (SSTR2), over-expressed in GEP-NETs and extensive stage small cell lung cancer (ES-SCLC).

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drugs 52

Drug Discovery World

SEPTEMBER 11, 2023

Ariceum Therapeutics, a biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, has dosed the first patient with its first-in-class lead molecule, satoreotide, targeting extensive stage small cell lung cancer (ES-SCLC), at the Murdoch University Health Center in Perth, Australia.

Containment 59

Containment Clinical Trials Clinical Trials Production 59

Pharma Business Blog

AUGUST 9, 2023

Für Sie als Entscheidungsträgerin und Entscheidungsträger wird es immer schwieriger, die gesetzlichen sowie behördlichen Vorgaben und Neuerungen sowohl effizient als auch kostengünstig einzuhalten. All dies bringt umsatzsteuerliche Herausforderungen mit sich, die es zu meistern gilt. MWST-Tagung führen wir am 21.

52

52

Medical Xpress

FEBRUARY 6, 2023

Now, researchers reporting in ACS ES&T Water address that last bit of wisdom, demonstrating that each flush can spit out thousands of virus particles from infected waste. Parents often give their children useful advice: Wash your hands, cover your cough and put the toilet lid down before flushing.

Research 74

Research 74

NY Times

JUNE 29, 2022

Brasil es un ejemplo de las posibles consecuencias de ese tipo de decisiones. Con la anulación del fallo de Roe contra Wade, diversas zonas de Estados Unidos buscan evitar la distribución de medicamentos para abortar.

Drugs 53

Drugs 53

NY Times

MAY 10, 2022

es cada vez más cada similar al consultorio de esta doctora en Kentucky, a donde llegan pacientes cada 15 minutos. El panorama de la atención a la salud mental de los adolescentes en EE.

Drugs 54

Drugs 54

NY Times

NOVEMBER 29, 2021

Si no es así, serán necesarias revisiones. Una “mezcla tipo Frankenstein” de mutaciones suscita preocupación, pero la variante puede seguir siendo vulnerable a las vacunas actuales.

Vaccination 54

Vaccination Vaccine Drugs 54

NY Times

FEBRUARY 11, 2022

Pero es posible que la FDA autorice las primeras dos dosis de cualquier manera. No está claro si tres dosis de la vacuna Pfizer-BioNTech protegerán adecuadamente a los niños.

Clinical Trials 52

Clinical Trials Clinical Trials Drugs Vaccination 52

NY Times

OCTOBER 29, 2021

autorizaron la combinación de vacunas en la dosis de refuerzo contra la covid, pero no han indicado cuál es la mejor opción. Las autoridades sanitarias de EE.

Vaccination 55

Vaccination Vaccine Drugs 55

NY Times

MAY 6, 2021

Es una sociopatía supercapitalista y, también, prueba de que la experiencia pandémica ha sido deformada por internet. La pandemia se ha transformado en entretenimiento en Estados Unidos.

Vaccination 55

Vaccination Vaccine Drugs 55

NY Times

FEBRUARY 7, 2022

El certificado estadounidense no cabe en la billetera, así que no es de extrañar que lo hayas extraviado.

Drugs 53

Drugs 53

NY Times

MARCH 10, 2022

Una de las causas más comunes es la cafeína, o la falta de ella. Y ¿hay algo que pueda hacer para evitarlo?

Drugs 52

Drugs 52

NY Times

MAY 17, 2021

La esperanza es que los nuevos tratamientos animen a la gente a considerar la obesidad como una condición crónica, como la hipertensión o la diabetes.

Clinical Trials 53

Clinical Trials Clinical Trials Drugs Trials 53

NY Times

OCTOBER 14, 2020

No hay forma de saber cuál es la mejor. Al llegar la primavera tal vez habrá varias vacunas disponibles en Estados Unidos, todas regulares.

63

63

NY Times

DECEMBER 1, 2020

Esto es lo que esperamos, junto con las respuestas a otras preguntas sobre la nueva vacuna. Un panel asesor de los CDC decidirá sus recomendaciones el martes por la tarde.

Vaccination 53

Vaccination Vaccine Drugs 53

NY Times

NOVEMBER 16, 2020

Moderna es la segunda compañía que informa de los resultados preliminares de un gran ensayo de una vacuna. Pero todavía faltan meses para que esté ampliamente disponible para el público.

54

54

NY Times

MAY 18, 2021

Es un inmenso problema: no hay suficientes vacunas y aún menos para los países pobres. Tiene solución?

Vaccination 55

Vaccination Vaccine Drugs Development 55

Pharmaceutical Technology

DECEMBER 29, 2022

It has also been approved in Japan, EU, China, the US, as well as in many other countries to treat extensive-stage small cell lung cancer (ES-SCLC). The human monoclonal antibody, imfinzi (durvalumab) has been designed to bind to the PD-L1 protein and block the PD-L1 interaction with the PD-1 and CD80 proteins.

Protein 130

Protein Antibody Trials 130

Pharma Business Blog

AUGUST 29, 2022

Für Sie als Entscheidungsträger im Pharma & Life Sciences Bereich, wird es immer schwieriger all die gesetzlichen und behördlichen Vorgaben und Neuerungen effizient als auch kostengünstig einzuhalten. Es gilt, alle diese Faktoren in Ihrem Unternehmen aufeinander abzustimmen, Chancen zu ergreifen und Hürden erfolgreich zu bewältigen.

Life Science 52

Life Science 52

Scienmag

APRIL 5, 2021

Credit: College of AC ES, University of Illinois. URBANA, Ill. ¬- If your day started with a cup of coffee, there’s a good chance your morning brew came from Colombia. Home to some of the finest Arabica beans, the country is the world’s third largest coffee producer.

Production 52

Production 52

Scienmag

OCTOBER 13, 2021

Isaac Lyatuu of the Ifakara Health Institute in Dar es Salaam, Tanzania, and colleagues […].

Engineer 52

Engineer 52

pharmaphorum

MARCH 30, 2022

Roche pointed out that ES-SCLC is challenging, and Tecentriq plus chemo remains the standard of care for patients, but the setbacks is a blow to its attempts to show that two immunotherapies can be better than one, increasing the proportion of patients who respond.

Drugs 97

Drugs FDA Approval Trials Clinical Trials 97

Pharma Business Blog

SEPTEMBER 20, 2021

Für Sie als Entscheidungsträger im Pharma & Life Sciences Bereich, wird es immer schwieriger all die gesetzlichen und behördlichen Vorgaben / Neuerungen effizient und kostengünstig einzuhalten. Dazu kommt die anhaltende COVID-19-Situation, welche umsatzsteuerliche Herausforderungen mit sich bringt und die es zu meistern gilt.

Life Science 52

Life Science Compliance 52

Pharma Business Blog

OCTOBER 15, 2020

Für Sie als Entscheidungsträger im Pharma & Life Sciences Bereich, wird es immer schwieriger all die gesetzlichen und behördlichen Vorgaben / Neuerungen effizient und kostengünstig einzuhalten. Dazu kommt die aktuelle COVID-19 Situation, welche umsatzsteuerliche Herausforderungen mit sich bringt und die es zu meistern gilt.

Life Science 52

Life Science 52

BioTech 365

AUGUST 27, 2020

27, 2020 (GLOBE NEWSWIRE) — Afya Limited, or Afya (Nasdaq: AFYA) today announced it entered into a purchase agreement for the acquisition, through its wholly-owned subsidiary Afya Participações S.A., NOVA LIMA, Brazil and MINAS GERAIS, Brazil, Aug. of 100% of … Continue reading →

40

40

BioTech 365

AUGUST 20, 2020

20, 2020 (GLOBE NEWSWIRE) — Afya Limited, or Afya (Nasdaq: AFYA) today announced it entered into a purchase agreement for the acquisition, through its wholly-owned subsidiary Afya Participações S.A., NOVA LIMA, Brazil and MINAS GERAIS, Brazil, Aug. of 100% of … Continue reading →

40

40

Scienmag

DECEMBER 14, 2020

Scientists achieve precision control of collective light emission from multiple nano-systems for the very first time – article in “Communications Physics” ‘Wie man in den Wald hineinruft, so schallt es heraus’ (‘shout into the forest and a similar echo will return’, or ‘What goes around, comes around’), (..)

Scientist 40

Scientist 40

Pharma Business Blog

JULY 14, 2020

Für Sie als Entscheidungsträger im Pharma & Life Sciences Bereich, wird es immer schwieriger all die gesetzlichen und behördlichen Vorgaben / Neuerungen effizient und kostengünstig einzuhalten. Dazu kommt die aktuelle COVID-19 Situation, welche umsatzsteuerliche Herausforderungen mit sich bringt und die es zu meistern gilt.

Life Science 52

Life Science 52

pharmaphorum

MAY 11, 2022

When tiragolumab missed the mark in the SKYSCRAPER-02 trial in extensive stage small-cell lung cancer (ES-SCLC) in January, Roche said it was a challenging indication, and it was hoping for better results in the SKYSCRAPER-01 study in non-small cell lung cancer (NSCLC).

Trials 58

Trials Clinical Trials Clinical Trials Drugs 58

Drug Discovery World

SEPTEMBER 15, 2023

First patient dosed in Phase Ib study in small cell lung cancer Ariceum Therapeutics, a biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, has dosed the first patient with its first-in-class lead molecule, satoreotide, targeting extensive stage small cell lung cancer (ES-SCLC).

Drugs 52

Drugs RNA Pharma Companies Vaccination 52

pharmaphorum

AUGUST 18, 2020

The regulator has granted a faster six-month Priority Review for the fixed dose regimen, based on data from several Imfinzi clinical trials, including results from the phase III CASPIAN trial in extensive stage small-cell lung cancer (ES-SCLC) which used the four-week, fixed-dose regimen during maintenance.

Doctors 52

Doctors Doctor Compliance Trials 52

Clinical Trial Podcast

OCTOBER 1, 2022

Our guest today is Anca Copaescu (CO PAH ES COO), CEO at Strategikon Pharma. If you’re a sponsor responsible for outsourcing your clinical trials or someone who is curious about what clinical trial outsourcing entails, you’re in for a treat.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Outsourcing 52

Pharmaceutical Technology

NOVEMBER 16, 2022

Opinion: COP27 comes after a year of unfulfilled COP26 promis es , by Nick Ferris (11 November). C OP27: “Green hydrogen is one of the bright spots of this COP” – Jonas Moberg, CEO of GH2 , by Nour Ghantous (14 November). COP27: Ukraine energy company DTEK maintains net-zero goal , by Nour Ghantous (14 November).

Marketing 130

Marketing Development 130